“…This is a fair characterization of many alliances in the industry. However, as a different body of work on the origins and evolution of biotechnology firms has illuminated, many biotech firms maintain close links with universities (see for example, Liebeskind et al, 1996;Audretsch and Stephan, 1996;Powell et al, 1996;Zucker et al, 1998;George et al, 2002;Murray and Stern, in press). Indeed, with just a handful of exceptions, the drugs on the market today with biotechnological origins have emanated from license agreements for scientific discoveries made in universities (Edwards et al, 2003).…”